This page is being served from the Urological Sciences Research Foundation web repository, and was originally posted between 1996-2008. In January 2009 USRF’s founder, Dr. Leonard S. Marks and his staff joined UCLA’s Department of Urology where they are continuing their research. Click for more information.

this is a navigational image map, please load this image to continue.
Next Last Index Home
Slide 15 of 18
5ARI drugs reduce the risk of acute urinary retention (AUR). The MTOPS study (Medical Therapy of Prostatic Symptoms) showed that compared to alpha-blockers, a 5ARI drug finasteride reduced the risk of AUR. Symptomatic relief was greatest with both drugs used together, but protection from BPH disease was primarily related to the 5ARI component.

this is a navigational image map, please load this image to continue.